Industry Watch

2006 ◽  
Vol 10 (03) ◽  
pp. 156-164

Biosignal & US Surgical Collaborate to Test Anti-biofilm on Catheters. Stem Cell Sciences and the University of Edinburgh Announce New Technology Transfer Agreement. CyGenics Expands Cord Blood Banking into India. Japan's Bioventures Today—TMRC Co Ltd. MerLion Pharmaceuticals Announces Drug Discovery Collaboration with Novartis Institute for Tropical Diseases. Taiwan's Vectorite Biomedical Collaborates with AMDL.

2012 ◽  
Vol 16 (12) ◽  
pp. 26-57

Metabolic Syndrome and Diabetes: Current Asian Perspectives.A Crisis in the Development of Antibiotics.The Marketing of Unapproved Stem Cell Products: An Industry-wide Challenge.Draining the Goodwill of Science – The Direct-to-Consumer Genetic Testing Industry in East Asia.Biodiesel – From Lab to Industry.The Appearance and Development of Commercial Laboratories in China.Cord Blood Banking – To Go Public or Stay Private.Open Source – The Future of Drug Discovery.VACCINES – Where are we headed?Leveraging on External Expertise.


2010 ◽  
Vol 20 (3) ◽  
pp. 185-190 ◽  
Author(s):  
M. Screnci ◽  
E. Murgi ◽  
D. Carmini ◽  
L. Piro ◽  
N. Cinelli ◽  
...  

2018 ◽  
Vol 11 (8) ◽  
pp. 649-661
Author(s):  
Luciana Teofili ◽  
Antonietta R. Silini ◽  
Maria Bianchi ◽  
Caterina Giovanna Valentini ◽  
Ornella Parolini

1970 ◽  
Vol 27 (1) ◽  
pp. 39-44
Author(s):  
Jahanara Rahman

Umbilical cord blood (UCB) is a source of premature haemopoietic stem cells (HSC) and progenitor cells which has a tremendous capacity to differentiate into another type of cell. Many malignant and non-malignant disorders are being treated with the transplantation of the UCB cells. This precious thing is usually discarded. But it can be easily and safely collected, cryopreserved and stored in a cord blood bank. UCB banks are being established in many countries of the world. Two models of cord blood banking systems are available-one is Family or private banking where UCB is stored for the benefit of the donor or their family and another is non-profitable public banking where UCB is stored for research purpose and for allogeneic unrelated transplantation. About seventy diseases can be treated with UCB transplantation. But, there are many debates regarding cord blood transplantation and legal and ethical issues cause to concern. However, UCB has become an established alternative to bone marrow transplantation in children and young adults. Key words: Stem cell, cord blood banking, stem cell transplantation. DOI: 10.3329/jbcps.v27i1.4242 J Bangladesh Coll Phys Surg 2009; 27: 39-44


2012 ◽  
Vol 21 (1) ◽  
pp. 1-6 ◽  
Author(s):  
Deepa Bhartiya ◽  
Ambreen Shaikh ◽  
Punam Nagvenkar ◽  
Sandhya Kasiviswanathan ◽  
Prasad Pethe ◽  
...  

2011 ◽  
Vol 20 (1) ◽  
pp. 54-60 ◽  
Author(s):  
Renece Waller-Wise

Umbilical cord blood was once thought of as a waste product. Now, years after the first successful umbilical cord blood transplant, more families seek information about whether or not to save their newborn’s cord blood. Childbirth educators may be one of the main sources that an expectant family depends on to gain more knowledge about cord blood banking in order to make an informed decision. Preserving umbilical cord blood in public banks is advisable for any family; however, it is recommended that expectant families only consider private cord blood banking when they have a relative with a known disorder that is treatable by stem cell transplants. The childbirth educator is encouraged to be well versed on the topic of cord blood banking, so that as questions from class participants arise, the topic can be explored and addressed appropriately.


2001 ◽  
Vol 20 (2) ◽  
pp. 167-174 ◽  
Author(s):  
William Reed ◽  
Mark Walters ◽  
Elizabeth Trachtenberg ◽  
Renee Smith ◽  
Bertram Lubin

Sign in / Sign up

Export Citation Format

Share Document